Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAIN: IV to Oral Antibiotic Switch in Neonatal Infection
NCT03247920Phase 4Completed
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Nov 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amoxicillin + clavulanate in neonatal infection and neonatal sepsis (2 arms), sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Bacterial re-infection within 28 days after finishing of antibacterial therapy. Started Nov 2017; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
neonatal infectionneonatal sepsis
Beyond the preview
Go deeper on NCT03247920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03247920.